HBVtech
Break cycles of infection and cure infection
HBVtech is a biopharma startup located in Frederick, MD. HBVtech focuses on research and development of a single injection-based hepatitis B drug to cure hepatitis B virus (HBV) infection. HBV infection is a major infectious disease globally, with approximately 302 million people chronically infected and nearly one million die of HBV-related liver diseases each year.
Science, Technologies and Products
Break cycles of infection and cure infection. HBVtech is a biopharma startup located in Frederick, Maryland.
Science
Science behind the new HBV cure strategy. Chronic HBV infection is conventionally thought to result from a continuation of unresolved initial HBV infection.
Technologies
Technology Platform.
A sustained high level of endogenously expressed anti-HBs antibody is required to durably block new rounds of infection.